We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

145 hedge funds and large institutions have $291M invested in Filana Therapeutics in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 28

47% more call options, than puts

Call options by funds: $54.8M | Put options by funds: $37.2M

1.72% more ownership

Funds ownership: 26.96% → 28.68% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 153 → 145 (-8)

12% less capital invested

Capital invested by funds: $332M → $291M (-$41.4M)

29% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 24

Holders
145
Holders Change
-8
Holders Change %
-5.23%
% of All Funds
2.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
58
Reduced
28
Closed
24
Calls
$54.8M
Puts
$37.2M
Net Calls
+$17.6M
Net Calls Change
-$10.5M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.48M
2
SG Americas Securities
SG Americas Securities
New York
+$3.98M
3
Bank of America
Bank of America
North Carolina
+$3.26M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.94M
5
JFG
Jefferies Financial Group
New York
+$2.65M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$3.45M
2
Group One Trading
Group One Trading
Illinois
-$2.9M
3
Goldman Sachs
Goldman Sachs
New York
-$2.65M
4
SC
Sculptor Capital
New York
-$2.11M
5
Morgan Stanley
Morgan Stanley
New York
-$1.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMT
126
Founders Capital Management (Texas)
Texas
$2K – – –
SWA
127
SOA Wealth Advisors
New York
$1.88K -$5.54K -200 -72%
SPIA
128
Steward Partners Investment Advisory
New York
$1.81K – – –
BWM
129
BerganKDV Wealth Management
Minnesota
$1.21K – – –
HPC
130
HM Payson & Co
Maine
$1.21K – – –
IGWM
131
ICA Group Wealth Management
Colorado
$1.21K – – –
SSB
132
Sandy Spring Bank
Maryland
$1.21K – – –
CWA
133
Carolina Wealth Advisors
South Carolina
$1.16K – – –
S
134
SignatureFD
Georgia
$1.13K -$2.05K -74 -61%
PA
135
Parallel Advisors
California
$796 +$637 +23 +230%
SWM
136
Spire Wealth Management
Virginia
$724 – – –
AAS
137
Ameritas Advisory Services
Nebraska
$724 +$831 +30 New
Commonwealth Equity Services
138
Commonwealth Equity Services
Massachusetts
$718 +$176K +6,352 +27%
BAM
139
Belpointe Asset Management
Nevada
$603 – – –
IA
140
IFP Advisors
Florida
$571 – – –
AF
141
Allworth Financial
California
$459 +$526 +19 New
NC
142
NewSquare Capital
Pennsylvania
$289 – – –
QCG
143
Quadrant Capital Group
Ohio
$145 +$166 +6 New
EWA
144
EverSource Wealth Advisors
Alabama
$121 – – –
Group One Trading
145
Group One Trading
Illinois
– -$2.9M -104,520 Closed
SC
146
Sculptor Capital
New York
– -$2.11M -71,500 Closed
IMC Chicago
147
IMC Chicago
Illinois
– -$1.72M -62,149 Closed
HIS
148
Harvest Investment Services
Illinois
– -$311K -10,530 Closed
VF
149
Virtu Financial
New York
– -$297K -10,044 Closed
Envestnet Asset Management
150
Envestnet Asset Management
Illinois
– -$228K -7,721 Closed
3 4 5
6
7

FLNA Hedge Fund Activity: Q1 2023 in Review

145 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2023, worth a combined $291M — down 12% from $332M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of FLNA and 17 opened new positions — a net loss of 7 holders — while 28 trimmed existing stakes and 58 added.

The largest buyer was Susquehanna International Group, adding an estimated $4.48M. The largest seller was Invesco, cutting an estimated $3.45M.

  • 145 institutional investors held Filana Therapeutics (FLNA) as of Q1 2023, down from 153 in Q4 2022.
  • Funds reported $291M of Filana Therapeutics stock for Q1 2023, down 12% quarter-over-quarter.
  • 17 funds opened new Filana Therapeutics positions in Q1 2023 and 24 closed out, a net change of -7 holders.
  • The largest Filana Therapeutics buyer in Q1 2023 was Susquehanna International Group, an estimated $4.48M added.
  • The largest Filana Therapeutics seller in Q1 2023 was Invesco, an estimated $3.45M sold.

Based on aggregated 13F filings for Q1 2023.